skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Journals@Ovid Complete remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Measuring Progress and Well-Being: A Comparative Review of Indicators
Measuring Progress and Well-Being: A Comparative Review of Indicators
Material Type:
Artigo 		Adicionar ao Meu Espaço

Measuring Progress and Well-Being: A Comparative Review of Indicators

Barrington-Leigh, Christopher ; Escande, Alice

Social indicators research, 2018-02, Vol.135 (3), p.893-925 [Periódico revisado por pares]

Dordrecht: Springer Science + Business Media

Texto completo disponível

Citações Citado por
2
TP009/#1495  A phase 2, open-label, single-arm, prospective, multi-center study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer
TP009/#1495  A phase 2, open-label, single-arm, prospective, multi-center study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

TP009/#1495  A phase 2, open-label, single-arm, prospective, multi-center study of nab-sirolimus plus letrozole in advanced or recurrent endometrioid endometrial cancer

Dockery, Lauren ; Priebe, Anna ; Duska, Linda ; Green, Angela ; Mathews, Cara ; Musa, Fernanda ; O’Malley, David ; Puechl, Allison ; Ding, Li ; Schmid, Anita ; Navarro, Willis ; Slomovitz, Brian ; Moore, Kathleen

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A249-A250 [Periódico revisado por pares]

Oxford: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por
3
TP021/#1540  Reframe-O1/ENGOT-OV79/GOG-3086: a phase 2/3 open-label study evaluating the efficacy and safety of luveltamab tazevibulin versus investigator’s choice chemotherapy in relapsed platinum-resistant EOC expressing folate receptor-alpha
TP021/#1540  Reframe-O1/ENGOT-OV79/GOG-3086: a phase 2/3 open-label study evaluating the efficacy and safety of luveltamab tazevibulin versus investigator’s choice chemotherapy in relapsed platinum-resistant EOC expressing folate receptor-alpha
Material Type:
Artigo 		Adicionar ao Meu Espaço

TP021/#1540  Reframe-O1/ENGOT-OV79/GOG-3086: a phase 2/3 open-label study evaluating the efficacy and safety of luveltamab tazevibulin versus investigator’s choice chemotherapy in relapsed platinum-resistant EOC expressing folate receptor-alpha

Wendel Naumann, R ; González-Martín, Antonio ; Herzog, Thomas ; Coleman, Robert ; Ray-Coquard, Isabelle ; Miller, Rowan ; Lu, Lin ; Dokainish, Hatem ; Berman, Craig ; Oaknin, Ana

International journal of gynecological cancer, 2023-11, Vol.33 (Suppl 4), p.A255-A255 [Periódico revisado por pares]

Oxford: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por
4
Non-farm employment, natural resource extraction, and poverty: evidence from household data for rural Vietnam
Non-farm employment, natural resource extraction, and poverty: evidence from household data for rural Vietnam
Material Type:
Artigo 		Adicionar ao Meu Espaço

Non-farm employment, natural resource extraction, and poverty: evidence from household data for rural Vietnam

Do, Manh Hung ; Nguyen, Trung Thanh ; Halkos, George ; Grote, Ulrike

Environment, development and sustainability, 2022-05, p.1-38 [Periódico revisado por pares]

Netherlands: Springer Netherlands

Texto completo disponível

Citações Citado por
5
The Start of Something Good: The Discovery of HbA1c and the American Diabetes Association Samuel Rahbar Outstanding Discovery Award
The Start of Something Good: The Discovery of HbA1c and the American Diabetes Association Samuel Rahbar Outstanding Discovery Award
Material Type:
Artigo 		Adicionar ao Meu Espaço

The Start of Something Good: The Discovery of HbA1c and the American Diabetes Association Samuel Rahbar Outstanding Discovery Award

Gebel, Erika

Diabetes care, 2012-12, Vol.35 (12), p.2429-2431 [Periódico revisado por pares]

American Diabetes Association

Texto completo disponível

Citações Citado por
6
TP009/#1444 Compare surgical staging with imaging in locally advanced cervical cancer: a multicenter, phase III trial
TP009/#1444 Compare surgical staging with imaging in locally advanced cervical cancer: a multicenter, phase III trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

TP009/#1444 Compare surgical staging with imaging in locally advanced cervical cancer: a multicenter, phase III trial

He, Misi ; Wang, Haixia ; Guo, Mingfang ; Wang, Ling ; Tang, Ying ; Zhou, Qi ; Zou, Dongling

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A227-A227 [Periódico revisado por pares]

Oxford: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por
7
TP043/#1565 Phase II activity trial of high dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: groningen international study on sentinel nodes in vulvar cancer III (GROINSS-V III/NRG-GY024)
TP043/#1565 Phase II activity trial of high dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: groningen international study on sentinel nodes in vulvar cancer III (GROINSS-V III/NRG-GY024)
Material Type:
Artigo 		Adicionar ao Meu Espaço

TP043/#1565 Phase II activity trial of high dose radiation and chemosensitization in patients with macrometastatic lymph node spread after sentinel node biopsy in vulvar cancer: groningen international study on sentinel nodes in vulvar cancer III (GROINSS-V III/NRG-GY024)

Gien, Lilian ; Slomovitz, Brian ; Leitao, Mario ; Zee, Ate Gj Van Der ; Creutzberg, Carien ; Reyners, An Kl ; Witteveen, Petronella ; Ayala-Peacock, Diandra ; Mayadev, Jyoti ; Iii, Charles Leath ; Oonk, Maaike

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A244-A244 [Periódico revisado por pares]

Oxford: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por
8
TP036/#426 Uplift (ENGOT-OV67/GOG-3048) a pivotal cohort of the XMT-1536–1 trial of upifitamab rilsodotin (XMT-1536; UPRI), a NAPI2B-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer
TP036/#426 Uplift (ENGOT-OV67/GOG-3048) a pivotal cohort of the XMT-1536–1 trial of upifitamab rilsodotin (XMT-1536; UPRI), a NAPI2B-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

TP036/#426 Uplift (ENGOT-OV67/GOG-3048) a pivotal cohort of the XMT-1536–1 trial of upifitamab rilsodotin (XMT-1536; UPRI), a NAPI2B-directed antibody drug conjugate (ADC) in platinum-resistant ovarian cancer

Richardson, Debra ; Perez Fidalgo, Jose Alejandro ; Gonzalez-Martin, Antonio ; Oaknin, Ana ; Hamilton, Erika ; Hays, John ; Pothuri, Bhavana ; Papadopoulos, Kyriakos ; Taylor, Sara ; Huang, Marilyn ; Lee, Yeh-Chen ; Krivak, Thomas ; Moreno-Garcia, Victor ; Calvo, Emiliano ; Randall, Leslie ; Starks, David ; Ross, Malcom ; Duska, Linda ; Gao, Bo ; Poka, Robert ; Putiri, Emily ; Barrett, Jamie ; Demars, Leslie ; Concin, Nicole

International journal of gynecological cancer, 2022-12, Vol.32 (Suppl 3), p.A241-A241 [Periódico revisado por pares]

Oxford: BMJ Publishing Group Ltd

Texto completo disponível

Citações Citado por
9
AML-274 TAGALONG Trial: Phase II Study of Tagraxofusp and Azacitidine With or Without Venetoclax in Newly Diagnosed Secondary AML after Previous Exposure to Hypomethylating Agents
AML-274 TAGALONG Trial: Phase II Study of Tagraxofusp and Azacitidine With or Without Venetoclax in Newly Diagnosed Secondary AML after Previous Exposure to Hypomethylating Agents
Material Type:
Artigo 		Adicionar ao Meu Espaço

AML-274 TAGALONG Trial: Phase II Study of Tagraxofusp and Azacitidine With or Without Venetoclax in Newly Diagnosed Secondary AML after Previous Exposure to Hypomethylating Agents

Green, Steven ; Parkin, Brian ; Lai, Catherine ; Gojo, Ivana ; Zeidner, Joshua

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S284-S284 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
10
How Career and Non-Work Goal Progress Affect Dual Earners’ Satisfaction: A Whole-Life Perspective
How Career and Non-Work Goal Progress Affect Dual Earners’ Satisfaction: A Whole-Life Perspective
Material Type:
Artigo 		Adicionar ao Meu Espaço

How Career and Non-Work Goal Progress Affect Dual Earners’ Satisfaction: A Whole-Life Perspective

Abraham, Elisabeth ; Verbruggen, Marijke ; Hirschi, Andreas

Journal of career development, 2024-04, Vol.51 (2), p.164-182 [Periódico revisado por pares]

Los Angeles, CA: SAGE Publications

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (2.475)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (2.560)
  2. Resenhas  (17)
  3. magazinearticle  (5)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1960  (99)
  2. 1960Até1975  (72)
  3. 1976Até1990  (133)
  4. 1991Até2006  (496)
  5. Após 2006  (1.784)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (2.576)
  2. Japonês  (154)
  3. Francês  (8)
  4. Alemão  (3)
  5. Português  (1)
  6. Chinês  (1)
  7. Espanhol  (1)
  8. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.